Compare EIX & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EIX | CNC |
|---|---|---|
| Founded | 1886 | 1984 |
| Country | United States | United States |
| Employees | 13725 | N/A |
| Industry | Electric Utilities: Central | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1B | 32.1B |
| IPO Year | 1994 | 2001 |
| Metric | EIX | CNC |
|---|---|---|
| Price | $72.63 | $65.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $72.09 | $46.75 |
| AVG Volume (30 Days) | 2.3M | ★ 3.5M |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | ★ 5.17% | N/A |
| EPS Growth | ★ 248.94 | N/A |
| EPS | 1.37 | ★ 3.11 |
| Revenue | $19,317,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | N/A | $8.31 |
| Revenue Next Year | $3.17 | $1.05 |
| P/E Ratio | $52.83 | ★ $20.43 |
| Revenue Growth | 9.76 | ★ 19.44 |
| 52 Week Low | $47.73 | $25.08 |
| 52 Week High | $76.22 | $66.55 |
| Indicator | EIX | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 57.45 | 68.23 |
| Support Level | $68.62 | $33.00 |
| Resistance Level | $73.87 | N/A |
| Average True Range (ATR) | 1.46 | 2.19 |
| MACD | 0.19 | -0.08 |
| Stochastic Oscillator | 75.30 | 87.26 |
Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.